CClinicalTrials.gg
CompletedNCT03876691Updated Mar 15, 2019

SHARE Model Communication Course and Do-not-resuscitate Signing

An observational study in Trauma Injury, sponsored by Chang Gung Memorial Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-03-15.

Sponsored by Chang Gung Memorial Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
145
Ages
20 Years to 100 Years
Sex
All
01

Study summary

This study aimed to investigate the effect of attending a SHARE model communication course by emergency physicians on patient notification and signing of do-not-resuscitate (DNR) orders for critical patients in the emergency room.

Read the detailed description

An observation form designed based on the SHARE model was completed by two observers who noted the communication process between physicians and patients and family members during patient notification and signing a DNR order. To assess the influence of physicians attending a SHARE model course on the signing of DNR orders, a propensity score-matched population was created to reduce the potential selection bias of patients and family members.

02

Conditions studied

  • Trauma Injury
03

In context

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The research subjects consisted of attending physicians, who were willing to inform consent forms, in the emergency department between May 2017 and April 2018.

Inclusion criteria

  • Patients who are considered as terminally ill and would not benefit from aggressive treatment, who physicians suggest to family about a "Do not resuscitate" order.
  • Patients who was not register with "Do- not- resuscitate" on their health insurance card.

Exclusion criteria

Exclusion Criteria:

  • Trauma patients.
  • Suicide patients.
  • Patients of age less than 20.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
145 participants (actual)
Patient registry
No

Groups and cohorts

  • Do not resuscitate

    Patients who are suggested to family about a do-not-resuscitate order treatment by physicians.

    Other: Patients · Other: Physician

Interventions

  • OtherPatients

    Patients who are considered as terminally ill and would not benefit from aggressive treatment, who physicians suggest to family about a do-not-resuscitate.

  • OtherPhysician

    The current emergency medical department departments within the preparation of the attending physician

06

What researchers measure

Primary outcomes

  1. Number of participants with DNR singing observation form

    The content of the observation form was filled by observers during the explanation process

    Time frame: up to 5 months

07

Study locations

1 site
  • Kaohsiung Chang Gung Memorial Hospital
    Kaohsiung, 83301, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03876691
Lead sponsor
Chang Gung Memorial Hospital
Responsible party
Sponsor
First posted
Mar 15, 2019
Start date
May 22, 2017
Primary completion
Apr 20, 2018
Completion
May 21, 2018
Last update
Mar 15, 2019

Study contacts

TSANG-TANG Hsieh, MD
study chair · Chang Gung Memorial Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion